Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Taps Aurora Co-founder Harry Stylli as New CEO

NEW YORK, June 1 (GenomeWeb News) - Sequenom has named Harry Stylli CEO and president, the company said today.


He comes to the San Diego-based firm from protein therapeutics firm Xencor of Monrovia, Calif., where he was president and CEO, and where he will remain a director. Sequenom has been without a full-time chief since February, when Toni Schuh resigned. Stylli takes over from Steve Zaniboni, who led Sequenom on an interim basis.


Prior to Xencor, he was president, CEO, and a co-founder of therapeutic antibody maker CovX Pharmaceuticals.


Stylli also co-founded Aurora Biosciences in 1995, where he was senior vice president of screening technology and new ventures, and later senior vice president of commercial development. In 2001, when Aurorawas acquired by Vertex Pharmaceuticals, he became president of Aurora and Panvera, another subsidiary of Vertex.


As part of his employment package at Sequenom, Stylli received stock options for 1 million shares of common stock.


Stylli holds a PhD from LondonUniversity's faculty of medicine, an MBA from the Open University in the UK, and a bachelor's of science degree from the Universityof East London.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.